Compounds, Compositions and Methods (2017)
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 5 of these applications claim priority to application 62/417,219, filed Nov 3, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,815,850 | Compounds, Compositions and Methods In force · High confidence UsedRemaining | Denali Therapeutics Inc. | In force | High confidence | ||
| US 9,896,458 | Compounds, Compositions and Methods In force · Medium confidence | Denali Therapeutics Inc. | In force | Medium confidence | ||
| US 10,131,676 | Compounds, Compositions and Methods In force · High confidence | Denali Therapeutics Inc. | In force | High confidence | ||
| US 10,604,535 | Compounds, Compositions and Methods In force · High confidence | Denali Therapeutics Inc. | In force | High confidence | ||
| US 12,358,928 | Compounds, Compositions and Methods In force · Medium confidence | Denali Therapeutics Inc. | In force | Medium confidence | ||
| Application 16/782,446 | Compounds, Compositions and Methods Abandoned Abandoned Apr 5, 2021 | Denali Therapeutics Inc. | Abandoned | Abandoned Apr 5, 2021 | ||
| Application 17/185,684 | Compounds, Compositions and Methods Abandoned Abandoned Jan 19, 2024 | Denali Therapeutics Inc. | Abandoned | Abandoned Jan 19, 2024 | ||
| Application 19/229,139 | Compounds, Compositions and Methods Pending Not granted | Denali Therapeutics Inc. | Pending | Not granted |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
5 of these are in force and held by Denali Therapeutics Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.